Pfizer requests FDA nod for COVID-19 shot in kids 5 to 11, but convincing parents might be a tough sell

Following a successful trial of their COVID-19 vaccine on children aged 5 to 11, Pfizer and BioNTech have asked the FDA for authorization in this age group. (Fierce Pharma)

Leave a Reply

Your email address will not be published. Required fields are marked *